Literature DB >> 6404282

Phosphorylation of a mast cell protein in response to treatment with anti-allergic compounds. Implications for the mode of action of sodium cromoglycate.

E Wells, J Mann.   

Abstract

Challenge of rat peritoneal mast cells with anti-rat IgE induces a similar pattern of protein phosphorylation to that already reported for compound 48/80. Rapid phosphorylation of a mast cell protein, mol. wt 78,000, is induced by sodium cromoglycate and several chemically related anti-allergic agents in the absence of any challenge. Phosphorylation of this protein reflects their potency in inhibiting anti-IgE-induced histamine release. Compounds which inhibit histamine release by elevating intracellular cAMP levels do not induce phosphorylation. However, dibutyryl-cGMP induces phosphorylation of the 78,000 mol. wt protein in the absence of any challenge, at concns which inhibit IgE-dependent histamine release. Sodium cromoglycate appears to activate an endogenous control mechanism for switching off mediator release using a mechanism mediated by cGMP.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6404282     DOI: 10.1016/0006-2952(83)90585-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  21 in total

1.  Is inhibition of mast cell mediator release relevant to the clinical activity of anti-allergic drugs?

Authors:  M K Church
Journal:  Agents Actions       Date:  1986-06

2.  The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells.

Authors:  Zuyi Weng; Arti B Patel; Smaro Panagiotidou; Theoharis C Theoharides
Journal:  J Allergy Clin Immunol       Date:  2014-12-10       Impact factor: 10.793

3.  Inhibitory effects of nedocromil sodium on the in vitro induced migration and leukotriene formation of human granulocytes.

Authors:  P L Bruijnzeel; R A Warringa; P T Kok; M L Hamelink; J Kreukniet
Journal:  Drugs       Date:  1989       Impact factor: 9.546

4.  REV 2871 (CHBZ): a novel inhibitor of histamine release.

Authors:  S M Coutts; A Khandwala; T S Shoupe; J H Musser; L J Klunk; I Weinryb
Journal:  Agents Actions       Date:  1986-06

5.  Antagonists of luteinizing hormone releasing hormone bind to rat mast cells and induce histamine release.

Authors:  K Sundaram; A Didolkar; R Thau; M Chaudhuri; F Schmidt
Journal:  Agents Actions       Date:  1988-12

6.  Characterization of purification-associated reduction in IgE-dependent histamine release from rat peritoneal mast cells.

Authors:  N Inagaki; H Kawasaki; H Nagai
Journal:  Inflamm Res       Date:  1995-12       Impact factor: 4.575

7.  Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from mast cells from various locations.

Authors:  F L Pearce; M Al-Laith; L Bosman; J Brostoff; T M Cunniffe; K C Flint; B N Hudspith; Z H Jaffar; N M Johnson; T A Kassessinoff
Journal:  Drugs       Date:  1989       Impact factor: 9.546

8.  Mast cells at the host-pathogen interface: host-protection versus immune evasion in leishmaniasis.

Authors:  B Saha; A M D J Tonkal; S Croft; S Roy
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

9.  Effect of triphenyltin chloride on the release of histamine from mast cells.

Authors:  H Nishida; H Matsui; H Nagai
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

10.  Role of sodium cromoglycate on analgesia, locomotor activity and opiate withdrawal in mice.

Authors:  J C Leza; I Lizasoain; O S Martín-Clark; P Lorenzo
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.